These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7439114)

  • 21. Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series.
    Singer C; Papapetropoulos S; Gonzalez MA; Roberts EL; Lieberman A
    Mov Disord; 2005 Jul; 20(7):873-7. PubMed ID: 15809995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corneal endothelial dysfunction associated with amantadine toxicity.
    Chang KC; Kim MK; Wee WR; Lee JH
    Cornea; 2008 Dec; 27(10):1182-5. PubMed ID: 19034138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)].
    Shiozawa R; Kase M; Kuroiwa Y; Narabayashi H; Nishitani Y; Ohmoto T; Toyokura Y; Uono K
    No To Shinkei; 1981 Mar; 33(3):301-9. PubMed ID: 7018522
    [No Abstract]   [Full Text] [Related]  

  • 25. Twenty-five years of amantadine therapy in Parkinson's disease.
    Danielczyk W
    J Neural Transm Suppl; 1995; 46():399-405. PubMed ID: 8821075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visual impairment in Parkinson's disease treated with amantadine: case report and review of the literature.
    Kubo S; Iwatake A; Ebihara N; Murakami A; Hattori N
    Parkinsonism Relat Disord; 2008; 14(2):166-9. PubMed ID: 17509924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Crises in the course of Parkinson's disease].
    Danielczyk W
    Wien Med Wochenschr; 1980 Feb; 130(4):149-51. PubMed ID: 7376682
    [No Abstract]   [Full Text] [Related]  

  • 28. Visual hallucinations and delirium during treatment with amantadine (Symmetrel).
    Postma JU; Van Tilburg W
    J Am Geriatr Soc; 1975 May; 23(5):212-5. PubMed ID: 123540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amantadine in the treatment of Parkinson's disease].
    Giombini S; Solero CL; Bazzan A; Ferrari P; Robotti E
    Fracastoro; 1970; 63(6):869-81. PubMed ID: 5519639
    [No Abstract]   [Full Text] [Related]  

  • 30. Amantadine-induced livedo reticularis: a report of two cases.
    Hayes BB; Cook-Norris RH; Miller JL; Rodriguez A; Zic JA
    J Drugs Dermatol; 2006 Mar; 5(3):288-9. PubMed ID: 16573266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experiences with amantadine hydrochloride in Parkinson's disease.
    Griffiths AV; Parker WN; Palmer RM
    Practitioner; 1971 Nov; 207(241):679-80. PubMed ID: 5134819
    [No Abstract]   [Full Text] [Related]  

  • 32. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys.
    Blanchet PJ; Konitsiotis S; Chase TN
    Mov Disord; 1998 Sep; 13(5):798-802. PubMed ID: 9756148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of amantadine on neuroleptic-induced parkinsonism.
    Rüther E; Fussmann-Hegewald M; Eben E
    Act Nerv Super (Praha); 1973 May; 15(2):93. PubMed ID: 4148089
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of Parkinson's disease with amantadine (Symmetrel).
    van Manen J
    Psychiatr Neurol Neurochir; 1972; 75(1):49-59. PubMed ID: 5024896
    [No Abstract]   [Full Text] [Related]  

  • 35. Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease.
    Silver DE; Sahs AL
    Trans Am Neurol Assoc; 1971; 96():307-8. PubMed ID: 4945919
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current treatment of the Parkinsonian syndrome].
    Voiculescu V
    Neurol Psihiatr Neurochir; 1973; 18(6):519-23. PubMed ID: 4790485
    [No Abstract]   [Full Text] [Related]  

  • 37. Parkinson's disease.
    Barboi AC; Goetz CG
    Clin Neuropharmacol; 1999; 22(4):184-91. PubMed ID: 10442246
    [No Abstract]   [Full Text] [Related]  

  • 38. [Amantadine for the treatment of levodopa dyskinesias in Parkinson's disease].
    Cersósimo MG; Scorticati MC; Micheli FE
    Medicina (B Aires); 2000; 60(3):321-5. PubMed ID: 11050808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.
    Koziorowski D; Friedman A
    Mov Disord; 2007 May; 22(7):1033-6. PubMed ID: 17370308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient].
    Ceballos-Baumann AO
    MMW Fortschr Med; 2002 May; Suppl 2():37-43. PubMed ID: 12070848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.